Physician profile
Michael E Cole
NPI 1598812463
$3,075.28
in general payments reported to CMS, 2019-2025
25 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $683 · 2021: $380 · 2022: $657 · 2023: $310 · 2024: $564 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,081.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $774.92 | 2020-2024 | |
| Abbvie INC. | $482.09 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Channel Medsystems, INC. | $229.31 | 2022-2024 | |
| Coopersurgical, INC. | $217.27 | 2019-2025 | Endosee, Summit Doppler |
| Astellas Pharma US INC | $177.79 | 2019-2024 | Veozah |
| Organon LLC | $158.96 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $157.98 | 2019-2025 | |
| Sage Therapeutics, LLC | $140.12 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $120.26 | 2022 | |
| Exeltis, USA INC. | $112.66 | 2021-2025 | Slynd |
| Medtronic, INC. | $98.79 | 2023-2025 | V-Loc 180, Truclear |
| Sumitomo Pharma America, INC. | $91.04 | 2023-2024 | Myfembree |
| Allergan, INC. | $48.78 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $43.09 | 2021 | |
| Mylan Pharmaceuticals INC. | $37.28 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $32.47 | 2022 | |
| Millicent US INC | $29.21 | 2024 | Intrarosa |
| Avion Pharmaceuticals | $25.70 | 2021 | |
| Boston Scientific Corporation | $19.65 | 2019 | |
| Merck Sharp & Dohme LLC | $18.17 | 2021 | |
| Exact Sciences Corporation | $13.24 | 2023 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $12.72 | 2022 | |
| Meditrina | $11.42 | 2024 | |
| Evofem Biosciences, INC. | $11.25 | 2021 | |
| Hologic Sales and Service, LLC | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.